Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)
- Previous Close
18.15 - Open
18.15 - Bid 17.50 x --
- Ask 17.65 x --
- Day's Range
16.90 - 18.15 - 52 Week Range
14.30 - 22.70 - Volume
177,006 - Avg. Volume
151,658 - Market Cap (intraday)
1.279B - Beta (5Y Monthly) 0.22
- PE Ratio (TTM)
-- - EPS (TTM)
-2.19 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 8, 2023
- 1y Target Est
--
Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan.
www.genomics.com.twRecent News: 4195.TWO
View MorePerformance Overview: 4195.TWO
Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4195.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4195.TWO
View MoreValuation Measures
Market Cap
1.31B
Enterprise Value
1.43B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.15
Price/Book (mrq)
1.88
Enterprise Value/Revenue
3.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-38.00%
Return on Assets (ttm)
-5.36%
Return on Equity (ttm)
-19.45%
Revenue (ttm)
417.04M
Net Income Avi to Common (ttm)
-158.49M
Diluted EPS (ttm)
-2.19
Balance Sheet and Cash Flow
Total Cash (mrq)
261.42M
Total Debt/Equity (mrq)
48.88%
Levered Free Cash Flow (ttm)
-262.69M